Week of February 19 - 25, 2017
Radiation fibrosis syndrome is a common late side effect of radiation in the treatment of head and neck cancer.
Information about the side effect trismus and how it is treated.
Information about Spinal Accessory Nerve Palsy, a side effect of some treatments for head and neck cancers.
Post-transplant lymphoproliferative disorders (PTLD) are a type of lymphoma that are a complication of both solid organ and allogeneic bone marrow or stem cell transplants.
This webinar provides an introduction to the treatment of head and neck cancers, with a focus on radiation therapy and specifically the treatment of head and neck cancers with proton therapy.
Information about dental care specifically for head and neck cancer survivors.
Provides support and coping information for body image changes during and after head and neck cancer treatment
A look at the role the medical oncology team plays in the interdisciplinary care of head and neck cancer.
Rucaparib is a PARP (poly ADP ribose polymerase) inhibitor. Cancers related to BRCA 1 or 2 mutations seem to rely on PARP to repair damaged DNA in cancer cells, allowing them to continue to divide. By inhibiting PARP, tumor growth may be slowed or stopped. A blood test is required prior to starting treatment with rucaparib to determine if you have a BRCA mutation.
A look at the multidisciplinary team in head and neck cancer care and the evaluations needed before treatment can begin.
An introduction to head and neck cancers, their diagnosis and treatment.
A review of surgical procedures used in the treatment of oropharyngeal cancers.
This webinar looks at the clinical considerations in the planning, development, and operation of a proton therapy facility, with emphasis on quality, safety and clinical excellence.
A parotidectomy is a surgical procedure done to remove the parotid gland, which is the largest of the body’s salivary glands.